Strides Pharma Science Limited — Updates, 21-07-2026: General Updates
21-07-2026 | 03:36 pm
21-07-2026 | 03:36 pm
Strides Pharma reported 3 voluntary product recalls due to quality issues. Exports comprise 90.66% of turnover. Related party transactions are significant at 86.40% of sales and 99.58% of investments. Employee well-being spending dropped to 0.44% of revenue. `2.88 Cr` spent on CSR.
No comments yet. Be the first to comment!
